Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone D'adamio

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Molecular Diagnosis & Therapy|April 5, 2017
The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the LiteratureMarina Talamonti, Simone D'Adamio, Luca Bianchi, et al.
Expert Opinion on Biological Therapy|March 9, 2017
Tildrakizumab for treating psoriasisMarco Galluzzo, Simone D'adamio, Luca Bianchi, et al.
The Journal of Dermatological Treatment|April 21, 2018
Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumabMarco Galluzzo, Simone D'Adamio, Luca Bianchi, et al.
Dermatologic Therapy|April 11, 2019
Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literatureMarco Galluzzo, Simone D'Adamio, Miriam Teoli, et al.
Dermatology (Basel, Switzerland)|February 3, 2017
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 PatientsMarina Talamonti, Marco Galluzzo, Stella Servoli, et al.
Molecular Diagnosis & Therapy|August 5, 2018
Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast TherapyMarco Galluzzo, Simone D'Adamio, Elena Campione, et al.
Expert Opinion on Biological Therapy|December 28, 2019
In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasisMarco Galluzzo, Simone D'Adamio, Dionisio Silvaggio, et al.
Dermatologic Therapy|April 11, 2019
Successful treatment of psoriatic crumbly nails with ustekinumabMarco Galluzzo, Simone D'Adamio, Maria Sole Chimenti, et al.
Expert Opinion on Biological Therapy|December 19, 2017
Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patientsMarco Galluzzo, Simone D'Adamio, Roberta Pastorino, et al.
Expert Opinion on Biological Therapy|May 26, 2018
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observationMarco Galluzzo, Marina Talamonti, Clara De Simone, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Molecular Diagnosis & Therapy|April 5, 2017
The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the LiteratureMarina Talamonti, Simone D'Adamio, Luca Bianchi, et al.
Expert Opinion on Biological Therapy|March 9, 2017
Tildrakizumab for treating psoriasisMarco Galluzzo, Simone D'adamio, Luca Bianchi, et al.
The Journal of Dermatological Treatment|April 21, 2018
Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumabMarco Galluzzo, Simone D'Adamio, Luca Bianchi, et al.
Dermatologic Therapy|April 11, 2019
Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literatureMarco Galluzzo, Simone D'Adamio, Miriam Teoli, et al.
Dermatology (Basel, Switzerland)|February 3, 2017
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 PatientsMarina Talamonti, Marco Galluzzo, Stella Servoli, et al.
Molecular Diagnosis & Therapy|August 5, 2018
Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast TherapyMarco Galluzzo, Simone D'Adamio, Elena Campione, et al.
Expert Opinion on Biological Therapy|December 28, 2019
In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasisMarco Galluzzo, Simone D'Adamio, Dionisio Silvaggio, et al.
Dermatologic Therapy|April 11, 2019
Successful treatment of psoriatic crumbly nails with ustekinumabMarco Galluzzo, Simone D'Adamio, Maria Sole Chimenti, et al.
Expert Opinion on Biological Therapy|December 19, 2017
Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patientsMarco Galluzzo, Simone D'Adamio, Roberta Pastorino, et al.
Expert Opinion on Biological Therapy|May 26, 2018
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observationMarco Galluzzo, Marina Talamonti, Clara De Simone, et al.
Pageof 2